Afixba 2.5mg Tablet contains Apixaban as its active ingredient. It is classified as a direct oral anticoagulant (DOAC) and is used for preventing blood clots in various medical conditions. Apixaban works by inhibiting specific clotting factors, reducing the risk of stroke and systemic embolism.
- Apixaban: A direct oral anticoagulant that prevents blood clots by inhibiting specific clotting factors.
Afixba 2.5mg Tablet is prescribed for the following purposes:
- Atrial Fibrillation: To reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): Treatment and prevention of DVT and PE.
- Recurrent DVT and PE: Reduction of the risk of recurrent DVT and PE after initial treatment.
Dosage and Administration: The dosage of Afixba 2.5mg is determined by the healthcare provider based on the patient’s medical condition. It is usually taken orally with or without food, as directed.
- Bleeding Risk: Afixba increases the risk of bleeding, so precautions should be taken, especially in patients with a history of bleeding disorders or those taking other anticoagulants.
- Renal Impairment: Dose adjustments may be necessary in individuals with impaired renal function.
Common side effects include bleeding, bruising, and gastrointestinal disturbances. Serious but rare side effects may include severe bleeding and allergic reactions.
When Not to Use:
Afixba 2.5mg Tablet is contraindicated in individuals with a known hypersensitivity to Apixaban or any other components of the medication. It should not be used in patients with active bleeding.
Note: This information is a general overview of Afixba 2.5mg Tablet. Patients should consult their healthcare provider for personalized advice and appropriate dosage based on individual health conditions.